CD8A and hepatocellular carcinoma: DEX–CBX significantly increases the abundance of Akkermansia, a bacterium known to strengthen systemic immune responses, which enhances NK T cells, CD8+ T cells, and M2 macrophages, offering a novel strategy to precisely modulate hepatic inflammation and gut microbiota in HCC.